Development and Validation of a Predictive Model for Internal Hernia After Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid Score.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 06 2022
Historique:
pubmed: 20 10 2020
medline: 1 6 2022
entrez: 19 10 2020
Statut: ppublish

Résumé

The aim of this study was to develop and validate a prediction score for internal hernia (IH) after Roux-en-Y gastric bypass (RYGB). The clinical diagnosis of IH is challenging. A sensitivity of 63% to 92% was reported for computed tomography (CT). Consecutive patients admitted for abdominal pain after RYGB and undergoing CT and surgical exploration were included retrospectively. Potential clinical predictors and radiological signs of IH were entered in binary logistic regression analysis to determine a predictive score of surgically confirmed IH in the Geneva training set (January 2006-December 2014), and validated in 3 centers, Geneva (January 2015-December 2017) and Neuchâtel and Strasbourg (January 2012-December 2017). Two hundred twenty-eight patients were included, 80 of whom (35.5%) had surgically confirmed IH, 38 (16.6%) had a negative laparoscopy, and 110 (48.2%) had an alternate diagnosis. In the training set of 61 patients, excess body weight loss >95% (odds ratio [OR] 6.73, 95% confidence interval [CI]: 1.13-39.96), swirl sign (OR 8.93, 95% CI: 2.30-34.70), and free liquid (OR 4.53, 95% CI: 1.08-19.0) were independent predictors of IH. Area under the curve (AUC) of the score was 0.799. In the validation set of 167 patients, AUC was 0.846. A score ≥2 was associated with an IH incidence of 60.7% (34/56), and 5.3% (3/56) had a negative laparoscopy. The score could be incorporated in the clinical setting. To reduce the risk of delayed IH diagnosis, emergency explorative laparoscopy in patients with a score ≥ 2 should be considered.

Sections du résumé

OBJECTIVE
The aim of this study was to develop and validate a prediction score for internal hernia (IH) after Roux-en-Y gastric bypass (RYGB).
SUMMARY BACKGROUND DATA
The clinical diagnosis of IH is challenging. A sensitivity of 63% to 92% was reported for computed tomography (CT).
METHODS
Consecutive patients admitted for abdominal pain after RYGB and undergoing CT and surgical exploration were included retrospectively. Potential clinical predictors and radiological signs of IH were entered in binary logistic regression analysis to determine a predictive score of surgically confirmed IH in the Geneva training set (January 2006-December 2014), and validated in 3 centers, Geneva (January 2015-December 2017) and Neuchâtel and Strasbourg (January 2012-December 2017).
RESULTS
Two hundred twenty-eight patients were included, 80 of whom (35.5%) had surgically confirmed IH, 38 (16.6%) had a negative laparoscopy, and 110 (48.2%) had an alternate diagnosis. In the training set of 61 patients, excess body weight loss >95% (odds ratio [OR] 6.73, 95% confidence interval [CI]: 1.13-39.96), swirl sign (OR 8.93, 95% CI: 2.30-34.70), and free liquid (OR 4.53, 95% CI: 1.08-19.0) were independent predictors of IH. Area under the curve (AUC) of the score was 0.799. In the validation set of 167 patients, AUC was 0.846. A score ≥2 was associated with an IH incidence of 60.7% (34/56), and 5.3% (3/56) had a negative laparoscopy.
CONCLUSIONS
The score could be incorporated in the clinical setting. To reduce the risk of delayed IH diagnosis, emergency explorative laparoscopy in patients with a score ≥ 2 should be considered.

Identifiants

pubmed: 33074896
pii: 00000658-202206000-00017
doi: 10.1097/SLA.0000000000004370
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1137-1142

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and source of funding: JM is the president of the IRCAD institute which is partly funded by Karl Storz and Medtronic; CT received personal fees Intuitive Surgical Inc, Ethicon Inc. and Verb Sugical, outside this project; MH received personal fees and nonfinancial support form Intuitive Surgical Inc., Quantgene Inc., Ethicon Inc. and Verb Surgical, outside this project; MJ received personal fees from Intuitive Surgical Inc., Johnson and Johnson Incl., outside this project; for the remaining authors none were declared.

Références

Geubbels N, Lijftogt N, Fiocco M, et al. Meta-analysis of internal herniation after gastric bypass surgery. Br J Surg 2015; 102:451–460.
Al-Mansour MR, Mundy R, Canoy JM, et al. Internal hernia after laparoscopic antecolic Roux-en-Y gastric bypass. Obes Surg 2015; 25:2106–2111.
Farukhi MA, Mattingly MS, Clapp B, et al. CT scan reliability in detecting internal hernia after gastric bypass. JSLS 2017; 21:e2017.00054.
Alsulaimy M, Punchai S, Ali FA, et al. The utility of diagnostic laparoscopy in post-bariatric surgery patients with chronic abdominal pain of unknown etiology. Obes Surg 2017; 27:1924–1928.
Facchiano E, Leuratti L, Veltri M, et al. Laparoscopic management of internal hernia after Roux-en-Y gastric bypass. Obes Surg 2016; 26:1363–1365.
Sandvik J, Hole T, Klockner CA, et al. High-frequency of computer tomography and surgery for abdominal pain after Roux-en-Y Gastric Bypass. Obes Surg 2018; 28:2609–2616.
Goudsmedt F, Deylgat B, Coenegrachts K, et al. Internal hernia after laparoscopic Roux-en-Y gastric bypass: a correlation between radiological and operative findings. Obes Surg 2015; 25:622–627.
Dilauro M, McInnes MD, Schieda N, et al. Internal hernia after laparoscopic Roux-en-Y gastric bypass: optimal CT signs for diagnosis and clinical decision making. Radiology 2017; 282:752–760.
Klop C, Deden LN, Aarts EO, et al. Diagnosing internal herniation after Roux-en-Y gastric bypass surgery: literature overview, cadaver study and the added value of 3D CT angiography. Obes Surg 2018; 28:1822–1830.
Danshoj Kristensen S, Naver L, Jess P, et al. Reoperation risk following the first operation for internal herniation in patients with laparoscopic Roux-en-Y gastric bypass. Br J Surg 2016; 103:1184–1188.
Iannuccilli JD, Grand D, Murphy BL, et al. Sensitivity and specificity of eight CT signs in the preoperative diagnosis of internal mesenteric hernia following Roux-en-Y gastric bypass surgery. Clin Radiol 2009; 64:373–380.
Obeid A, Long J, Kakade M, et al. Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes. Surg Endosc 2012; 26:3515–3520.
Obeid A, McNeal S, Breland M, et al. Internal hernia after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg 2014; 18:250–255. discussion 255-6.
Stenberg E, Szabo E, Agren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet 2016; 387:1397–1404.
Rosas U, Ahmed S, Leva N, et al. Mesenteric defect closure in laparoscopic Roux-en-Y gastric bypass: a randomized controlled trial. Surg Endosc 2015; 29:2486–2490.
Pitt T, Brethauer S, Sherman V, et al. Diagnostic laparoscopy for chronic abdominal pain after gastric bypass. Surg Obes Relat Dis 2008; 4:394–398. discussion 398.
Merkow RP, Ju MH, Chung JW, et al. Underlying reasons associated with hospital readmission following surgery in the United States. Jama 2015; 313:483–495.
Geubbels N, Roell EA, Acherman YI, et al. Internal herniation after laparoscopic Roux-en-Y Gastric bypass surgery: pitfalls in diagnosing and the introduction of the AMSTERDAM Classification. Obes Surg 2016; 26:1859–1866.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg 2017; 27:2279–2289.
Summers RM. Progress in fully automated abdominal CT interpretation. AJR Am J Roentgenol 2016; 207:67–79.
Liu J, Lay N, Wei Z, et al. Colitis detection on abdominal CT scans by rich feature hierarchies. SPIE 2016; 9785.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care 2016; 39:861–877.

Auteurs

Guillaume Giudicelli (G)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.
Department of Surgery, Neuchâtel Hospital, Neuchâtel, Switzerland.

Pierre-Alexandre Poletti (PA)

Department of Radiology, Geneva University Hospital, Geneva, Switzerland.

Alexandra Platon (A)

IHU-Strasbourg, Institute of Image-guided Surgery, Strasbourg, France.

Jacques Marescaux (J)

IHU-Strasbourg, Institute of Image-guided Surgery, Strasbourg, France.

Michel Vix (M)

Department of Surgery, Strasbourg University Hospital, Strasbourg, France.

Michele Diana (M)

IHU-Strasbourg, Institute of Image-guided Surgery, Strasbourg, France.
Department of Surgery, Strasbourg University Hospital, Strasbourg, France.
Department of Surgery, Neuchâtel Hospital, Neuchâtel, Switzerland.

Alfonso Lapergola (A)

IHU-Strasbourg, Institute of Image-guided Surgery, Strasbourg, France.

Marc Worreth (M)

Department of Surgery, Neuchâtel Hospital, Neuchâtel, Switzerland.

Alend Saadi (A)

Department of Surgery, Neuchâtel Hospital, Neuchâtel, Switzerland.

Aurélie Bugmann (A)

Department of Surgery, Neuchâtel Hospital, Neuchâtel, Switzerland.

Philippe Morel (P)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Christian Toso (C)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Stefan Mönig (S)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Monika E Hagen (ME)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Minoa K Jung (MK)

Unit of Visceral Surgery, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH